CCX354
CCR3 antagonist 1
Plozalizumab
Leronlimab
Bertilimumab
Mogamulizumab
Carlumab
CKLF1-C19
Maceneolignan H
MK-0812
RS102895
Aplaviroc
CCR4 antagonist 4
BMS-817399
INCB 3284 dimesylate
IPG7236
SB-649701
CCR5 antagonist 2
CCR5 antagonist 3
Tivumecirnon